Hot of the breath: mortality as a primary end-point in IPF treatment trials: the best is the enemy of the good

MeSH terms

• Clinical Trials as Topic / methods*
• Clinical Trials, Phase III as Topic / methods
• Disease Progression
• Endpoint Determination
• Humans
• Idiopathic Pulmonary Fibrosis / diagnosis
• Idiopathic Pulmonary Fibrosis / mortality*
• Idiopathic Pulmonary Fibrosis / therapy*
• Research Design
• Treatment Outcome